Navigation Links
Consorta Receives Practice Greenhealth Champion for Change Award for Sixth Consecutive Year
Date:5/22/2009

r 3,000 ambulatory surgery centers, alternate care sites and physician practices, Consorta provides increasing levels of supply chain value to our shareholders and members.

About Practice Greenhealth

Practice Greenhealth is the nation's leading membership and networking organization for institutions in the healthcare community that have made a commitment to sustainable, eco-friendly practices. Members include hospitals, healthcare systems, businesses and other stakeholders engaged in the greening of healthcare to improve the health of patients, staff and the environment. Practice Greenhealth is a source of environmental solutions for the healthcare sector. For more information on Practice Greenhealth, healthy initiatives, current trends, news and views, and other links to earth-friendly organizations, visit www.practicegreenhealth.org.


'/>"/>
SOURCE Consorta, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Consorta Board Appoints Darrel Weatherford President and Chief Executive Officer
2. Christopher & Dana Reeve Foundation Receives $25,000 Gift from TD Bank
3. Go Healthy Receives Letter of Endorsement from the Texas Chiropractic Association, District Five State Director - Dr. Thomas Klesmit
4. Broadlane Receives Environmental Award for Excellence
5. The Club at Briarcliff Manor Receives Certificate of Authority from New York
6. CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence
7. Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity
8. Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device
9. Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement
10. SCM Microsystems Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program
11. BioMarin Receives 2009 Corporate Award for the Development of Kuvan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... become a mainstay of multiple myeloma treatment may ... of patients who have received stem cell transplants ... clinical trial results to be presented by ... Society of Hematology,s (ASH) annual meeting on Sunday, ... Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... cooperation with the Greater VA Healthcare System in West Los Angeles, ... expected to soar to more than 5,000 veterans, active military personnel ... ... 6, 2009 -- Volunteer organizations and members of the community, in ... will once again create a holiday party. This year,s attendance is ...
(Date:12/5/2009)... CAPE TOWN, South Africa, December 5 The ... outskirts of Cape Town opened its doors,today (5 ... joined by,Western Cape Premier Helen Zille, 2010 FIFA ... Jordaan, South African Football Association,President Kirsten Nematandani and ...
(Date:12/5/2009)... Technology Center helps companies develop and test their cleaning processes. The ... variety of industries and solve problems for customers relating to cleaning ... ... 5, 2009 -- Midbrook, Inc , a Jackson, MI-based company, ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... have identified a subgroup of hard-to-treat breast cancers that ... in the treatment of breast tumors. They also have ... help identify patients most likely to benefit from cisplatin ... trial anticipated to begin at the MGH Gillette Center ...
... a dermatologist has a higher survival rate than by a ... to detect// the tumor in its early stages which can ... ,Individuals whose melanoma is diagnosed by a dermatologist may be ... years than those with melanoma diagnosed by a non-dermatologist, according ...
... from the researchers from Yale School of Medicine and ... first time found evidence of a// molecular mechanism that ... ,This discovery may help the development of ... and for cognitive changes in schizophrenia, bipolar disorder, or ...
... a Mediterranean country, is considered notoriously image-conscious. It may be ... clashing fiercely all the time. ,But the thirst ... ,Only that should explain why the Fist National Bank has ... ,Its website dubs the 'plastic surgery loans' as ...
... have found that the use of remote monitoring ... potential to significantly// improve clinical outcomes (mortality, morbidity ... remote monitoring (telephone support or telemonitoring) to electronically ... pressure, weight and ECG and oxygen details, to ...
... An initiative focused on motivating seniors and others with Medicare ... off by the U.S. Department of Health and Human Services ... The campaign is titled: A Healthier US Starts Here. ... the spring and summer, the Medicare Prevention tour bus will ...
Other Medicine News:Health News:Researchers Have Identified Subgroup Sensitive to the Drug Cisplatin 2Health News:Chances of Survival for Melanoma is High When Detected by Dermatologists 2Health News:New Light on Working of Brain Networks 2Health News:New Light on Working of Brain Networks 3Health News:Loans for Cosmetic Surgery in Lebanon 2Health News:Research Uncovers the Significant Benefits of Remote Monitoring 2Health News:Seniors Encouraged To Make Use Of Medicare’s Freebie 2
(Date:12/4/2009)... MARLTON, N.J., Dec. 4 Thermographic Diagnostic Imaging ... in Marlton, New Jersey continues to provide superior ... thyroid, dental, TMJ and sinus regions to assist ... these areas. ,, Thermography utilizes infrared imaging ...
(Date:12/4/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... Principal investigators will discuss the data presentations surrounding ... at the 51st American Society of Hematology (ASH) Annual ... CT/10:00 a.m. ET on Monday, December 7, 2009. ...
(Date:12/4/2009)... (NYSE Amex: PIP ), a biodefense company developing ... the presentation of new data from the Company,s anthrax ... (rPA) based anthrax vaccine is structurally stable and potent ... including 55 degrees C. The data were presented ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 1YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 4NuVasive To Present at the Piper Jaffray Health Care Conference and the J P Morgan SMid Cap Conference 6488 1NuVasive To Present at the Piper Jaffray Health Care Conference and the J P Morgan SMid Cap Conference 6488 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J P Morgan SMid Cap Conference 6488 3West Announces Management Change 6485 1
... FREDERICK, Md., Jan. 7 ImQuest Life Sciences announced ... the Food and Drug Administration to initiate human clinical ... anticipates initiating their Phase 1 studies in the first ... inhibitor of HIV which primarily acts as a nonnucleoside ...
... a specialty,biopharmaceutical company focused on allergy and critical ... in 2008 with,its ToleroMune(R) anti-allergy technology, the company ... II clinical trial in cat allergy. The,study, which ... with confirmed,cat allergies, and all the participants have ...
Other Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3
... The AB Holter, a ... system, provides sophisticated,ambulatory ECG analysis ... Windows environment.,Designed to use Windows ... the system allows,the option of ...
Olive Shaped Tip Cannula With Straight Shaft; in stainless steel....
... Designed to meet the ... of cardiology practices. The ... attenuation correction accessory features ... array that increases the ...
Sharp diamond shaped double blade in stainless steel....
Medicine Products: